The comprehensive strategy of Issels Integrative Immuno-Oncology includes advanced gene-targeted cancer therapies when indicated and always tailored to the individual patients needs.

Gene-targeted cancer therapies are medications that block the growth and spread of cancerous cells by interfering with specific molecules needed for tumor growth and progression.

These gene-targeted therapies are designed to inhibit only cancerous cell replication and tumor growth, whereas traditional chemotherapy-based treatments destroy rapidly dividing cancerous as well as healthy non-cancerous cells alike.

Gene-targeted therapies, although chemical drugs, are not only less harmful to normal cells and less toxic than traditional chemotherapy, but they have also been shown to improve outcomes in patients who qualify for these treatments.

Targeted therapies are generally well tolerated and have less toxic side effects, but also have limitations. The main limitation is the potential of cells to develop resistance.

1. Most gene-targeted therapies recommended are oral, which allow patients relatively independent control over dosage and dosing schedule. Patients can continue treatment at home without the need for frequent return office visits, but rather with regular distant follow-up care.

2. Financial coverage and support of these expensive medications are usually available depending on insurance status and through manufacturer assistance programs based on certain qualifications.

3. We work with a specialized laboratory in the United States to determine the right targeted therapy for patients whose condition warrants the integration of these specialized therapies into their comprehensive immunotherapy treatment program.

More here:
Advanced Gene-Targeted Therapies - Alternative Cancer Clinics